Skip to main content
. 2022 Aug 31;71(5):667–675. doi: 10.33549/physiolres.934914

Fig. 2.

Fig. 2

MiR-15a-5p was promoted with Ang II treatment. (A) RT-qPCR was applied for validating miR-15a-5p expression in Ang II-induced VSMCs. (B) RT-qPCR was used for evaluating miR-15a-5p expression after miR-15a-5p suppression. (C) CCK-8 was applied to examine VSMC viabilities after miR-15a-5p inhibition. (D, E) Transwell was used to validate VSMC migratory capacities with suppressed miR-15a-5p. (F, G): Western blot was applied for analyzing MCP-1 and MMP-9 protein expressions with inhibited miR-15a-5p. ** P<0.05.